• 回答数

    1

  • 浏览数

    83

继续改一个
首页 > 医学论文 > cRGD在医学论文中是什么意思

1个回答 默认排序
  • 默认排序
  • 按时间排序

年糕年糕熊

已采纳

近5年来主要论著(SCI影响因子4以上的论文):. Cheng,G. Hong,W. Wang,R. Yuan,H. Ai,J. Shen*,B. Liang,J. Gao,X. Shuai*,“Nonclustered magnetite nanoparticle encapsulated biodegradable polymeric micelles with enhanced properties for in vivo tumor imaging”,J. Mater. Chem.,DOI:.(IF=). Cao,D. Cheng,S. Zou,H. Ai,J. Gao,X. Shuai*,“The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells”,Biomaterials,Doi:.(IF=)3. J. Dai,S. Zou,Y. Pei,D. Cheng,H. Ai,X. Shuai*,“Polyethylenimine-grafted Copolymer of Poly(L-lysine) and Poly(ethylene glycol) for Gene Delivery”,Biomaterials,Doi:.(IF=)4. G. Liu,Z. Wang,J. Lu,C. Xia,F. Gao,Q. Gong,B. Song,X. Zhao,X. Shuai,X. Chen,H. Ai,Z. Gu,“Low molecular weight alkyl-polycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo imaging”,Biomaterials,2011,2,528-537. (IF=)5. W. Zhang,Y. Li,L. Liu*,Q. Sun,X. Shuai*,W. Zhu,Y Chen*,“Amphiphilic Toothbrushlike Copolymers Based on Poly(ethylene glycol) and Poly(ε-caprolactone) as Drug Carriers with Enhanced Properties”,Biomacromolecules,2010,11,1331-1338.(IF=)6. B. Liang,M. He,C. Chan,Y. Chen,X. Li,Y. Li,D. Zheng,M. Lin,H. Kung,X. Shuai*,Ying Peng*,“The Use of Folate-PEG-grafted-hybranched-PEI Nonviral Vector for the Inhibition of Glioma Growth In The Rat”,Biomaterials 2009,30,4014-4020.(IF=)7. J. Lu,S. Ma,J. Sun,C. Xia,C. Liu,Z. Wang,X. Zhao,F. Gao,Q. Gong,B. Song,X. Shuai,Hua Ai,Zhongwei Gu,“Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging”,Biomaterials 2009,30,2919-2928.(IF=)8. G. Chen*,W. Chen,Z. Wu,R. Yuan,Hua Li,J. Gao,X. Shuai*,“MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression”,Biomaterials 2009,30,1962-1970.(IF=)9. H. Ai,C. Flask,B. Weinberg,X. Shuai,M. D. Pagel,D. Farrell,J. Duerk,J. Gao,“Magnetite-loaded polymeric micelles as novel magnetic resonance probe”,Adv. Mater. 2005,17,1949-1952.(IF=)10. S. Mao,X. Shuai,F. Unger,and T. Kissel,“Synthesis and characterization of water-soluble poly (ethylene glycol)-graft-trimethyl chitosan block copolymers and their application as insulin delivery carriers”,Biomaterials 2005,26,6343-6356.(IF=)11. X. Shuai,T. Merdan,F. Unger,T. Kissel,“Biodegradable Supra-molecular Vehicle Showing Combined Good Biocompatibility and High Gene Transfection Efficiency”,Bioconjugate Chem. 2005,16,322-329.(IF=)12. N. Nasongkla†,X. Shuai†,H. Ai,J. Gao,“cRGD-functionalized micelle (cRGD-PEG-PCL) for targeted doxorubicin delivery to tumor neovasculature”,Angew. Chem. Int. Edi. 2004,43,6323-6327.(共同第1,IF=)13. Y. Zhao,X. Shuai,C. Chen,F. Xi,“Synthesis of star block copolymers from dendrimer initiators by combing ring-opening polymerization and atom transfer radical polymerization”,Macromolecules 2004,37,8854-8862.(IF=)14. X. Shuai,H. Ai,N. Nasongkla,S. Kim,and J. Gao,“Micellar Carriers Based on Block Copolymers of Poly(e-caprolactone) and Poly(ethylene glycol) for Doxorubicin Delivery”,J. Controlled Release 2004,98,415-426.(IF=)15. X. Shuai,T. Merdan,and T. Kissel,“Core-crosslinked Polymeric Micelles as Paclitaxel carriers”,Bioconjugate Chem. 2004,15,441-448.(IF=)16. Y. Zhao,X. Shuai,C. Chen,F. Xi,“Synthesis of novel dendrimer-like star block copolymers with definite number of arms by combination of ROP and ATRP”,Chem. Commun. 2004,14,1608-1609.(IF=)17. X. Shuai,T. Merdan,F. Unger,W. Matthias,and T. Kissel,“Novel Biodegradable Ternary Copolymers hy-PEI-g-PCL-b-PEG: Synthesis,Characterization and Potential as Efficient Non-viral Gene Delivery Vectors”,Macromolecules 2003,36,5751-5759.(IF=)18. Y. Zhao,X. Shuai,C. Chen,F. Xi,“Synthesis and Characterization of Star-Shaped Poly(L-lactide)s Initiated with Hydroxyl-Terminated Poly(Amidoamine) (PAMAM-OH) Dendrimers”,Chem. Mater. 2003,15,2836-2843.(IF=)19. M. Wei,X. Shuai, A. E. Tonelli,“Melting and Crystallizatioin Behavior of Biodegradable Polymers Enzymatically Coalesced from Their Cyclodextrin Inclusion Complexes”,Biomacromolecules 2003,4,783-792.(IF=)20. X. Shuai,F. Porbeni,M. Wei,T. Bullions,A. E. Tonelli,“Stereo-selectivity in the Formation of Inclusion Complexes of Poly(3-hydroxybutyrate)s with Cyclodextrins”,Macromolecules 2002,35,3778-3780.(IF=)21. Y. Na,Y. He,X. Shuai,Y. Kikkawa,Y. Doi,and Y. Inoue,“Compatibilization Effect of Poly(e-caprolactone)-b-Poly(ethylene glycol) Block Copolymers and Phase Morphology Analysis in Immiscible Poly(lactide)/ Poly(e-caprolactone) Blends”,Biomacromolecules 2002,3,1179-1186.(IF=)22. X. Shuai,F. Porbeni,M. Wei,T. Bullions,A. E. Tonelli,“Formation of Inclusion Complexes of Poly(3-hydroxybutyrate)s with Cyclodextrins 1: Immobilization of Atactic Poly(R,S-3-hydroxybutyrate) and Miscibility Enhancement between Poly(R,S-3-hydroxy butyrate) and Poly(e-caprolactone)”,Macromolecules 2002,35,3126-3132.(IF=)23. X. Shuai,F. Porbeni,M. Wei,T. Bullions,A. E. Tonelli,“Inclusion Complex Formation between α,γ-Cyclodextrins and a Triblock Copolymer and the Cyclodextrin Type-Dependent Microphase Structures of their Coalesced Samples”,Macromolecules 2002,35,2401-2405. (IF=)24. X. Shuai,M. Wei,F. Porbeni,A. E. Tonelli,“Formation of and coalescence from the inclusion complex of a biodegradable block copolymer and a-cyclodextrin2: A novel means to modify the biodegradation behavor of biodegradable block copolymers”,Biomacromolecules 2002,3,201-207.(IF=)25. X. Shuai,F. Porbeni,M. Wei,I. Shin & A. E. Tonelli,“Formation of and coalescence from the inclusion complex of a biodegradable block copolymer and a-cyclodextrin: A novel means to modify the phase structure of biodegradable block copolymers”,Macromolecules 2001,34,7355-7361.(IF=)26. Y. He,J. Li,X. Shuai,Y. Inoue,“Reversible thinning/thickening phenomenon of polymer blends in aqueous media”,Macromolecules 2001,34,8166-8172.(IF=)27. Y. He,X. Shuai,A. Cao,K. Kasuya,Y. Doi,Y. Inoue,“Enzymatic biodegradation of synthetic atactic P(R,S-hydroxybutyrate) induced by amorphous polymer and the enzymatic degradation temperature window of amorphous systems”,Biomacromolecules 2001,2,1045-1051.(IF=)28. Y. He,He,X. Shuai,A. Cao,K. Kasuya,Y. Doi,Y. Inoue,Enzymatic biodegradation of chemosynthetic atactic P(3HB) enhanced by an amorphous non-biodegradable polymer: blend of atactic P(3HB) with PMMA,Macromol. Rapid Comm., 2000,21: 1277-1281.(IF= )

304 评论

相关问答

  • 在医学论文中asked什么意思

    1、参考文献类型:普通图书[M]、期刊文章[J]、报纸文章[N]、论文集[C]、学位论 文[D]、报告[R]、标准[s]、专利[P]、数据库[DB]、计算机程序

    井中月2500 6人参与回答 2023-12-10
  • 医学论文中是什么意思

    sci论文属于科技论文,具体详情,你可以去创先职称论文发表网看看。

    小月半月月 4人参与回答 2023-12-06
  • 医学论文中t是什么意思

    bp 的代表下面的含义1. BP(Boiling Point ),(物理学)沸点。2. BP(blood pressure),(医学)血压。3. Basis P

    麦麦舞雨 6人参与回答 2023-12-05
  • 医学论文中dpr是什么意思

    差异点位复核率是指在进行质量控制时,对同一批次产品中不同位置的样品进行检测,并计算出其中存在差异的样品所占比例。这个比例就是差异点位复核率。它可以用来评估生产过

    Too兔rich 3人参与回答 2023-12-10
  • gut是在医学期刊什么意思

    患肿瘤最可怕的是复发转移。 “槐耳颗粒”就可能阻断肿瘤的复发转移 ,因为它是被国际权威机构证实具有抑制肿瘤干细胞功效的药物。除“槐耳颗粒”外,目前还没有发现其他

    匪号叶小二 3人参与回答 2023-12-06